Drugs /
ixabepilone
Overview
Clinical Trials
Ixabepilone has been investigated in 3 clinical trials, of which 2 are open and 1 is closed. Of the trials investigating ixabepilone, 3 are phase 2 (2 open).
ER Negative, ER No Expression, and HER2 Deficient Expression are the most frequent biomarker inclusion criteria for ixabepilone clinical trials.
Breast carcinoma, fallopian tube carcinoma, and ovarian carcinoma are the most common diseases being investigated in ixabepilone clinical trials [2].
Drug Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].
2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.